A novel missense mutation in the second extracellular domain of GJB2, p.Ser183Phe, causes a syndrome of focal palmoplantar keratoderma with deafness.
Gap junctions, which consist of connexins, are intercellular channels that mediate rapid intercellular communication. In the skin, connexins are involved in the regulation of epidermal growth and differentiation. GJB2 encodes connexin26, which is an important skin-expressed gap junction protein. Mutations in GJB2 cause a wide variety of unique disorders, but despite extensive research, their mechanisms of action are poorly understood. The identification of novel diseases caused by mutations in GJB2 may help to illuminate the genotype-phenotype correlation and elucidate the function of different regions of the protein. Here, we report the first account of a family with a GJB2 missense mutation in the second extracellular domain (p.Ser183Phe) that causes skin abnormalities in addition to sensorineural hearing loss. Using fluorescent connexin26-EGFP fusion proteins, we showed that the mutation induces a partial protein transport defect that cannot be rescued by wild-type protein. Dye-transfer experiments using a parachute assay revealed channel functionality. Although p.Ser183Phe affects the second extracellular domain, mutations in the first extracellular domain also lead to focal palmoplantar keratoderma and likewise perturb protein transport in a dominant-negative manner. Therefore, we hypothesize that focal palmoplantar keratoderma in gap junction skin disease may be specifically associated with connexin trafficking defects as well as with mutations affecting its extracellular domains, thus broadening the spectrum of GJB2-associated diseases.
de Zwart-Storm
Eugene A
EA
Department of Dermatology, University Medical Center Maastricht, Maastricht, The Netherlands. edz@sder.azm.nl
van Geel
Michel
M
van Neer
Pierre A F A
PA
Steijlen
Peter M
PM
Martin
Patricia E
PE
van Steensel
Maurice A M
MA
D000328:Adult; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D001483:Base Sequence; D002675:Child, Preschool; D000072259:Connexin 26; D017630:Connexins / Q000737:chemistry* / Q000235:genetics*; D017124:Conserved Sequence; D004252:DNA Mutational Analysis; D003638:Deafness / Q000150:complications* / Q000235:genetics*; D005260:Female; D006367:HeLa Cells; D006319:Hearing Loss, Sensorineural / Q000150:complications / Q000235:genetics; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000150:complications* / Q000235:genetics*; D008297:Male; D008969:Molecular Sequence Data; D020125:Mutation, Missense / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D010649:Phenylalanine / Q000235:genetics; D017434:Protein Structure, Tertiary; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D012694:Serine / Q000235:genetics; D013577:Syndrome
D017630:Connexins; C000607042:GJB2 protein, human; D011993:Recombinant Fusion Proteins; D000072259:Connexin 26; D012694:Serine; D010649:Phenylalanine
Biochem Biophys Res Commun. 2005 Nov 25;337(3):799-805
16226720
Nucleic Acids Res. 1988 Feb 11;16(3):1215
3344216
Am J Med Genet C Semin Med Genet. 2004 Nov 15;131C(1):12-9
15468169
J Invest Dermatol. 2008 Apr;128(4):1039-49
17960178
Cancer Res. 1995 Feb 1;55(3):629-39
7834634
Biochim Biophys Acta. 2005 Jun 10;1711(2):126-41
15955298
Am J Med Genet A. 2007 Jul 15;143A(14):1567-73
17431919
J Invest Dermatol. 2007 Nov;127(11):2516-24
17934503
Hear Res. 2008 Jun;240(1-2):87-92
18472371
J Biol Chem. 2003 Jan 17;278(3):1807-16
12384501
Clin Genet. 2003 Jun;63(6):516-21
12786758
Br J Pharmacol. 2005 Mar;144(5):617-27
15678088
J Cell Sci. 2001 Nov;114(Pt 21):3845-55
11719551
Biochem J. 2006 Mar 15;394(Pt 3):527-43
16492141
J Med Genet. 2008 Mar;45(3):161-6
17993581
Hum Mol Genet. 2003 Apr 15;12(8):805-12
12668604
Hum Mutat. 2001;18(1):84-5
11439000
Biochem J. 2006 Jul 1;397(1):1-14
16761954